7 Years at AB|22 Years of Experience
Jonathan Berkow is a Senior Vice President and the Director of Quantitative Research and Data Science in the Equities division at AB. He leads the research and adoption of alternative data in equity research and systematic strategies. Prior to joining the firm in 2018, Berkow was a systematic portfolio manager and researcher at hedge funds Element Capital Management and Kepos Capital. He started his career at Goldman Sachs Asset Management, where he managed quantitative research and was a portfolio manager for global equity portfolios. Berkow's research has spanned equities and macro asset classes. He holds a BS in economics from the Massachusetts Institute of Technology. Location: New York
Risk management is being put to the test in 2025. How can equity portfolio teams cope with multiple hazards across equity markets this year?
Nelson Yu, Jonathan Berkow | 27 March 2025From stock picking to benchmark selection, the construction of an active thematic equity portfolio will play a crucial role in its ability to deliver on a theme’s return potential.
Dan Roarty, Jonathan Berkow | 13 November 2024Thematic portfolios that tap into big global trends offer exciting opportunities for equity investors. But the devil is in the detail.
Nelson Yu, Dan Roarty, Lei Qiu, Jonathan Berkow | 30 October 2024How can equity investors build portfolios that capture the potential of exciting thematic stories?
Nelson Yu, Dan Roarty, Lei Qiu, Jonathan Berkow | 26 September 2024Investors need a better grasp of risk-management tools to gauge a portfolio’s strategic resilience in a rapidly changing world.
Nelson Yu, Jonathan Berkow | 21 June 2024From potentially brand-damaging ethical risks to regulatory uncertainty, AI poses challenges for investors. But there is a path forward.
Jonathan Berkow | 30 May 2024There are different ways to apply AI to portfolio management processes. We discuss three distinct approaches in fixed income, hedge funds and equities.
Bernd Wuebben, Jonathan Berkow | 29 September 2023Many companies are talking up the potential of artificial intelligence. But equity investors shouldn’t jump blindly on the AI bandwagon.
Jonathan Berkow | 10 July 2023AI isn't going to replace human analysts anytime soon. But it can help execute many menial functions to free up analysts for deeper research dives, armed with more information than they could ever process alone.
Jonathan Berkow | 09 May 2023The race is on to redesign supply chains. Equity investors need a clear framework to figure out which companies are taking the right steps to adapt.
Erik Turenchalk, Jonathan Berkow, James MacGregor | 17 June 2022Data science and climate-change analysis are two leading-edge areas of innovation for investment management firms as the 2020’s unfold. In both cases, enhancing human capabilities is as important as upgrading technological prowess.
Jonathan Berkow | 28 September 2021US vacationers are out in force while the holiday scene remains subdued in Europe and Asia. How can equity investors capture the unfolding global mobility recovery?
James T. Tierney, Dev Chakrabarti, Jonathan Berkow | 06 August 2021Evaluating employee wellness can provide important investment insight on a company's ability to maintain a motivated and efficient workforce that can deliver better results over peers.
Jonathan Berkow, Ryan Oden | 29 June 2021Many investors are looking for emerging signs of a return to normalcy from the coronavirus crisis. While there are many indicators to choose from, we've assembled a group of signals, with the help of big data, that may point the way.
Scott Krauthamer, Jonathan Berkow | 03 June 2021Data science is most effective when it starts with a deep, fundamental question. What's the key question that the research is trying to answer? From that starting point, data scientists work very closely with research analysts to deploy the right data and tools to find an answer.
Chris Marx, Jonathan Berkow | 03 August 2020The COVID-19 crisis has made data science even more important. Today, data scientists are collaborating with research analysts to fill in the gaps with a few mouse clicks when social distancing restrictions limit the mobility of on-the-ground efforts.
Chris Marx, Jonathan Berkow | 28 July 2020This information is for exclusive use of the wholesale person to whom it is provided and is not to be relied upon by any other person. It is not intended for retail or public use and may not be further distributed without prior written consent of ABAL.
This webpage has been prepared by AllianceBernstein Australia Limited (“ABAL”)—ABN 53 095 022 718, AFSL 230 698. Information in this webpage is only intended for persons that qualify as “wholesale clients,” as defined by the Financial Markets Conduct Act 2013’, and is not to be construed as advice. This webpage is provided solely for informational purposes and is not an offer to buy or sell securities. The information, forecasts and opinions set forth in this webpage have not been prepared for any recipient’s specific investment objectives, financial situation or particular needs. Neither this webpage nor the information contained in it are intended to take the place of professional advice.
You should not take action on specific issues based on the information contained in this webpage without first obtaining professional advice. Past performance does not guarantee future results. Projections, although based on current information, may not be realized. Information, forecasts and opinions can change without notice and ABAL does not guarantee the accuracy of the information at any particular time. Although care has been exercised in compiling the information contained in this webpage, ABAL does not warrant that this webpage is free from errors, inaccuracies or omissions. ABAL disclaims any liability for damage or loss arising from reliance upon any matter contained in this webpage except for statutory liability which cannot be excluded.
No reproduction of the materials on this webpage may be made without the express written permission of ABAL. This information is provided for persons in Australia only and is not being provided for the use of any person who is in any other country.